Group Effect in Full Replicate Design [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2018-09-12 17:31 (2197 d 00:02 ago) – Posting: # 19278
Views: 7,293

Hi GM,

❝ ❝ For the ABE part (if swR <0.294) like the FDA’s Model II:



❝ But as per Progesterone Guidance, Treatment as random term in Average BE.


No way.

❝ Please see model SAS code from guidance.


MODEL LAUCT = SEQ PER TRT/ DDFM=SATTERTH;

❝ RANDOM TRT/TYPE=FA0(2) SUB=SUBJ G;


Please make yourself familiar with the syntax of SAS’ PROC MIXED. Terms in the MODEL argument are fixed.

❝ As per your version, Subject (nested within Group × Sequence) is the random term.


❝ Now am Confused:ponder:,Which is the correct one?


Mine. For the exact setup ask a qualified SAS-coder.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,226 posts in 4,879 threads, 1,657 registered users;
31 visitors (0 registered, 31 guests [including 7 identified bots]).
Forum time: 17:33 CEST (Europe/Vienna)

The real purpose of the scientific method is to make sure
nature hasn’t misled you into thinking you know something
you actually don’t know.    Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5